Drug
Setmelanotide
Setmelanotide: highest development phase Phase 3, developed by Rhythm Pharmaceuticals, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Rhythm Pharmaceuticals, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Setmelanotide NCT05093634 | Phase 3 | Obesity |
Latest
No recent events.
Follow Setmelanotide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.